Top Back to top

Patient, Family & Donor Day - Día del paciente, familia y donante

Please note that registration for this event is free of charge. On March 22nd, you may also return to this page and click the PFD Day Live Stream button to watch the sessions in real time, beginning at 9:00 Central European Time.

 

Fecha: 22 de marzo del 2020
Lugar: IFEMA (Centro de convenciones Norte - Sala N101), Madrid
Inscripción gratuita

Sunday, March 22nd

The Patient, Family and Donor Day has become an increasingly integral part of the yearly EBMT congress since it was first introduced at EBMT Lyon 2007. For the first time in Frankfurt 2019, the Patient, Family and Donor Day took place on the Sunday, and was also expanded to include two parallel sessions. 

One of the main goals is the improvement of the communication between EBMT professionals and patients. This is increasingly relevant due to the rapid evolution of technology associated to transplantation and its relationship with the growing field of cellular therapy. The introduction of new drugs and graft manipulation techniques, combined with changes in the clinical pattern of transplantation, particularly in the outpatient setting, has led to remarkable developments in the field over the last few years. The programme is aimed at exploring both scientific trends and the special relationship which is often created between the clinical BMT personnel and patients and their families.

The Patient, Family and Donor Day takes place on the Sunday, and registration for this unique and memorable day is free. All are welcome to attend!

Patient Advocates

The Patient Advocate sessions take place on Tuesday, March 24th. 

In Madrid 2020, EBMT will be offering full congress registration to 30 Patient Advocates.

If you are a Patient Advocate and are interested in attending the full EBMT Annual Meeting (March 22-25, 2020), in addition to Patient, Family and Donor Day, please APPLY by sending your CV and Letter of Intent to registration@ebmt.org. Once 30 applications have been received and approved, no further applications will be accepted.